Quantcast

Gaithersburg-based FedMed expands access to cancer tests

BioTheranostics Inc., a San Diego-based provider of genomic-based tools for cancer diagnosis, said it signed a contract with Gaithersburg-based FedMed Inc., one of the largest preferred provider organization networks in the United States, to provide access to bioTheranostics’ genomic tests for patients with breast cancer and metastatic cancers.